SG11202104743WA - Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeats - Google Patents

Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeats

Info

Publication number
SG11202104743WA
SG11202104743WA SG11202104743WA SG11202104743WA SG11202104743WA SG 11202104743W A SG11202104743W A SG 11202104743WA SG 11202104743W A SG11202104743W A SG 11202104743WA SG 11202104743W A SG11202104743W A SG 11202104743WA SG 11202104743W A SG11202104743W A SG 11202104743WA
Authority
SG
Singapore
Prior art keywords
modified
cedna
inverted terminal
terminal repeats
symmetrical
Prior art date
Application number
SG11202104743WA
Inventor
Robert Michael Kotin
Ozan Alkan
Annaliese Jones
Original Assignee
Generation Bio Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generation Bio Co filed Critical Generation Bio Co
Publication of SG11202104743WA publication Critical patent/SG11202104743WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
SG11202104743WA 2018-11-09 2019-11-08 Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeats SG11202104743WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862757872P 2018-11-09 2018-11-09
US201862757892P 2018-11-09 2018-11-09
PCT/US2019/060395 WO2020097417A1 (en) 2018-11-09 2019-11-08 Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeats

Publications (1)

Publication Number Publication Date
SG11202104743WA true SG11202104743WA (en) 2021-06-29

Family

ID=70612486

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202104743WA SG11202104743WA (en) 2018-11-09 2019-11-08 Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeats

Country Status (13)

Country Link
US (1) US20210388379A1 (en)
EP (1) EP3877528A4 (en)
JP (1) JP2022506771A (en)
KR (1) KR20210090619A (en)
CN (1) CN113316640A (en)
AU (1) AU2019376663A1 (en)
BR (1) BR112021007102A2 (en)
CA (1) CA3119310A1 (en)
IL (1) IL282925A (en)
MA (1) MA54188A (en)
MX (1) MX2021004842A (en)
SG (1) SG11202104743WA (en)
WO (1) WO2020097417A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3999646A4 (en) * 2019-07-17 2023-08-30 Generation Bio Co. Compositions and production of nicked closed-ended dna vectors
WO2021011842A1 (en) * 2019-07-17 2021-01-21 Generation Bio Co. Synthetic production of single-stranded adeno associated viral dna vectors
AU2021314809A1 (en) 2020-07-27 2023-02-23 Anjarium Biosciences Ag Compositions of DNA molecules, methods of making therefor, and methods of use thereof
CN117802161A (en) * 2022-06-30 2024-04-02 苏州吉恒基因科技有限公司 Accurate recombinant adeno-associated virus vector and application thereof
CN116110602B (en) * 2023-04-13 2023-06-20 云南医无界医疗网络科技有限公司 Information processing method and system applied to medical community

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2500434A1 (en) * 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
MX2018000307A (en) * 2015-06-23 2018-05-02 Childrens Hospital Philadelphia Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues.
CN109195636B (en) * 2016-03-03 2022-07-05 马萨诸塞大学 End-blocked linear duplex DNA for non-viral gene transfer
JP2021511047A (en) * 2018-01-19 2021-05-06 ジェネレーション バイオ カンパニー Process for obtaining closed-ended DNA vectors and ceDNA vectors that can be obtained from cell-free synthesis
MX2020008676A (en) * 2018-02-22 2020-09-25 Generation Bio Co Controlled expression of transgenes using close-ended dna (cedna) vectors.

Also Published As

Publication number Publication date
BR112021007102A2 (en) 2021-08-03
WO2020097417A9 (en) 2020-06-18
EP3877528A1 (en) 2021-09-15
JP2022506771A (en) 2022-01-17
AU2019376663A1 (en) 2021-06-24
CA3119310A1 (en) 2020-05-14
MX2021004842A (en) 2021-06-08
MA54188A (en) 2021-09-15
WO2020097417A1 (en) 2020-05-14
KR20210090619A (en) 2021-07-20
EP3877528A4 (en) 2022-11-30
IL282925A (en) 2021-06-30
US20210388379A1 (en) 2021-12-16
CN113316640A (en) 2021-08-27

Similar Documents

Publication Publication Date Title
IL272797A (en) Modified closed-ended dna (cedna)
IL282925A (en) Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeats
IL269458A (en) Nucleobase editors comprising nucleic acid programmable dna binding proteins
IL295358A (en) Using programmable dna binding proteins to enhance targeted genome modification
IL274926A (en) Engineered dna binding proteins
IL281980A (en) Fused pyrrolines which act as ubiquitin-specific protease 30 (usp30) inhibitors
IL281930A (en) Rna particles comprising polysarcosin
ZA202100242B (en) Recombinant nucleic acid construct
GB201812474D0 (en) Nucleic acid construct
IL286031A (en) Closed-ended dna (cedna) and immune modulating compounds
PT3833786T (en) Recombinant nucleic acid construct
ZA202006985B (en) Nucleic acid for treating crustacean allergy
GB201913898D0 (en) Nucleic acid construct
GB201815836D0 (en) Nucleic acid conjugates
GB201811074D0 (en) Nucleic acid conjugates